These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid. Vranka JA; Johnson E; Zhu X; Shepardson A; Alexander JP; Bradley JM; Wirtz MK; Weleber RG; Klein ML; Acott TS Curr Eye Res; 1997 Feb; 16(2):102-10. PubMed ID: 9068940 [TBL] [Abstract][Full Text] [Related]
9. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Kamei M; Hollyfield JG Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2367-75. PubMed ID: 10476804 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells. Majid MA; Smith VA; Easty DL; Baker AH; Newby AC Br J Ophthalmol; 2002 Jan; 86(1):97-101. PubMed ID: 11801512 [TBL] [Abstract][Full Text] [Related]
11. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix. Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR Matrix Biol; 2002 Jan; 21(1):75-88. PubMed ID: 11827795 [TBL] [Abstract][Full Text] [Related]
12. Sorsby's fundus dystrophy: what does TIMP3 tell us about general mechanisms underlying macular degeneration? Tymms MJ Clin Exp Optom; 1999; 82(4):124-129. PubMed ID: 12482286 [TBL] [Abstract][Full Text] [Related]
13. Sorsby's fundus dystrophy mutant tissue inhibitors of metalloproteinase-3 induce apoptosis of retinal pigment epithelial and MCF-7 cells. Majid MA; Smith VA; Easty DL; Baker AH; Newby AC FEBS Lett; 2002 Oct; 529(2-3):281-5. PubMed ID: 12372614 [TBL] [Abstract][Full Text] [Related]
14. Sorsby fundus dystrophy: Insights from the past and looking to the future. Anand-Apte B; Chao JR; Singh R; Stöhr H J Neurosci Res; 2019 Jan; 97(1):88-97. PubMed ID: 30129971 [TBL] [Abstract][Full Text] [Related]
15. Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis. Qi JH; Ebrahem Q; Yeow K; Edwards DR; Fox PL; Anand-Apte B J Biol Chem; 2002 Apr; 277(16):13394-400. PubMed ID: 11821400 [TBL] [Abstract][Full Text] [Related]
16. Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3. Majid MA; Smith VA; Newby AC; Dick AD Br J Ophthalmol; 2007 Aug; 91(8):1073-6. PubMed ID: 17383996 [TBL] [Abstract][Full Text] [Related]
17. Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby's Fundus Dystrophy. Gourier HC; Chong NV J Clin Med; 2015 May; 4(5):874-83. PubMed ID: 26239453 [TBL] [Abstract][Full Text] [Related]
18. In vitro stem cell modelling demonstrates a proof-of-concept for excess functional mutant TIMP3 as the cause of Sorsby fundus dystrophy. Hongisto H; Dewing JM; Christensen DR; Scott J; Cree AJ; Nättinen J; Määttä J; Jylhä A; Aapola U; Uusitalo H; Kaarniranta K; Ratnayaka JA; Skottman H; Lotery AJ J Pathol; 2020 Oct; 252(2):138-150. PubMed ID: 32666594 [TBL] [Abstract][Full Text] [Related]
19. Measurement of TIMP-3 expression and Bruch's membrane thickness in human macula. Bailey TA; Alexander RA; Dubovy SR; Luthert PJ; Chong NH Exp Eye Res; 2001 Dec; 73(6):851-8. PubMed ID: 11846515 [TBL] [Abstract][Full Text] [Related]
20. Tissue Inhibitor of Metalloproteinase 3 (TIMP3) mutations increase glycolytic activity and dysregulate glutamine metabolism in RPE cells. Grenell A; Singh C; Raju M; Wolk A; Dalvi S; Jang GF; Crabb JS; Hershberger CE; Manian KV; Hernandez K; Crabb JW; Singh R; Du J; Anand-Apte B Mol Metab; 2024 Oct; 88():101995. PubMed ID: 39047907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]